| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10907889 | Experimental Hematology | 2005 | 9 Pages |
Abstract
Autologous tumor vaccination at a time of ALL relapse is not feasible. Alternative strategies for immunotherapy of ALL may require ex vivo generation of antigen specific T cells and adoptive therapy.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
W. Nicholas Haining, Angelo A. Cardoso, Heather L. Keczkemethy, Mark Fleming, Donna Neuberg, Daniel J. DeAngelo, Richard M. Stone, Ilene Galinsky, Lewis B. Silverman, Stephen E. Sallan, Lee M. Nadler, Eva C. Guinan,